Abstract. The present study aimed to investigate the expression of the Hedgehog (Hh) signaling pathway between microsatellite-unstable (MSI) and microsatellite-unstable (MSS) colorectal cancers (CRCs). A total of 61 samples of CRC tissue and corresponding blood samples were obtained from the surgical department of our hospital. The tissue samples were examined by immunohistochemistry using antibodies against Sonic Hh (SHH), Pathed (PTCH) and Gli1, and evaluated independently for protein expression by two pathologists blinded to clinical outcome. Based on the immunohistochemistry results, SHH and PTCH expression varied in terms of histological type. In mucinous adenocarcinoma (MA) Hedgehog signaling was not highly expressed. There were more significant differences in the expression of SHH and PTCH (P<0.05), compared with Gli1. Moreover, significant differences were found in the expression of SHH, Gli1 and PTCH between the MSI and MSS groups (P<0.05). Hedgehog signals were more frequently expressed in the MSI group compared with the MSS group. In conclusion, this study indicates that the expression of the Hh signaling pathway may play a significant role in MSI in colorectal cancer.
Introduction
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Despite advances in early detection and improvements in diagnosis and scheduling of therapies in adjuvant and advanced settings, CRC is responsible for substantial mortality and is the leading cause of cancer-related death. CRC exhibits a significant heterogeneity even within the same pathologic stage in both prognosis and response to therapy (1) . The clinical heterogeneity may be a sign of underlying molecular heterogeneity in the pathogene sis of CRC. Current knowledge of molecular mechanisms involved in colorectal carcinogenesis indicates that CRC is a multi-pathway disease and two major genomic instability pathways are involved in its pathogenesis: microsatellite instability (MSI) and chromosome instability (CIN) . Approximately 15% of sporadic CRC is characterized by MSI, showing insertions and deletions in DNA microsatellite sequences, whereas the remaining 85% of CRC develops through the CIN pathway and is characterized by gross chromosomal alterations, either qualitative or quantitative. Although the MSI and CIN phenotypes may be distinguished from one another, evidence indicates some degree of overlap (2) .
The Hedgehog (Hh) signaling pathway is known to play a vital role in the proper development of the embryo (3). Thus, the Hh signaling pathway may play a crucial role in tumorigenesis when reactivated in adult tissues (4) (5) (6) (7) (8) . The involvement of the Hh signaling pathway in CRC has demonstrated that it is essential for human CRC growth, recurrence, metastases and stem cell expansion (9) . To gain further insight into the Hh signaling pathway in CRC, we investigated the expression of the Hh signaling pathway between MSI and microsatellitestable (MSS) colorectal cancer.
Materials and methods

Patients.
A total of 61 patients with sporadic CRC were included in this study. Sporadic CRC patients had no known familial history indicative of hereditary non-polyposis colorectal cancer or familial adenoid polyposis. Fresh colorectal carcinomas were obtained from surgical specimens from patients who underwent surgery in the Hospital. Sections from corresponding areas from the specimens submitted for diagnosis were cut into two parts: one part was snap-frozen in liquid nitrogen immediately following resection until processing for DNA isolation, while the other part was formalin-fixed and Table I . Laser fluorescence FAM was labeled on each pair's F primer. A total amount of 2 µl genomic DNA from blood samples and tumor tissue in each case was mixed with 2 µl primer pairs for the selected microsatellite markers, and 2 µl d NTP Mix, 2 µl 10X buffer and 0.2 µl Taq water were added to produce a final volume of 20 µl. The PCR conditions were: after an initial 2-min denaturation step at 95˚C, 40 amplification cycles were performed, each consisting of a 30-sec step at 95˚C, at 55˚C, and a 30-sec elongation step at 72˚C. Amplification was completed with a final incubation step at 72˚C for 7 min. MSI was defined by the presence of novel peaks or loss of bands, and shift of the peak following the PCR amplification of tumor DNA that were not present in normal DNA. A tumor was defined as high-MSI (MSI-H) if more than one of the five examined loci showed unequivocal instabilities. Tumors were classified as MSS if none or only one of the markers exhibited a shift.
Immunohistochemical analysis (IHC).
All tissues embedded in paraffin were sliced into 4-µm sections. The tissue were deparaffinized with xylene, rehydrated in a serial dilution of alcohol and immersed in 3% hydrogen peroxide to inhibit endogenous peroxidase activity. The sections were then incubated with various types of primary antibodies overnight at 4˚C. The nature, dilution ratio and recommended positive control tissues of the primary antibodies are shown in Table II . Slides were given three 5-min washes in phosphate-buffered saline (PBS) and incubated with the secondary antibodies and DAB color reagent (Supervision™ anti-rabbit detection reagent, Shanghai Changdao Biotech, Shanghai, China). The slides were counterstained with Mayer's hematoxylin, then dehydrated, and mounted with Canada balsam for examination. A recommended positive control tissue was used as the positive control for primary antibodies. Staining without the primary antibody was used as a negative control.
Immunohistochemical (IHC) scoring. The slides were evaluated independently for protein expression by two pathologists blinded to clinical outcome. When evaluations differed, a consensus interpretation was achieved using a 2-headed micro- nucleus but predominatly in cytoplasm (Fig. 1) . The positive frequency of SHH and Gli1 in all the cases was 54.1% (33/61), with SHH being higher at 62.3% (38/61). We divided these into positive and negative groups, and undertook an analysis of differentiation, stage, and histological type between the two groups (Table IV) . SHH was positively expressed (61.1%, 33/54) in more than half of the non-mucinous adenocarcinoma (NMA) samples, but was not expressed in mucinous adenocarcinoma (MA). This tendency was observed for PTCH, but not Gli1. In MA neither SHH nor PTCH were positive, but Gli1 was partly expressed. With regard to tumor differentiation, SHH and PTCH were expressed more highly in moderately differentiated tumors than poorly and well-differentiated tumors (SHH 62.5% vs. 25% and 0%, P<0.005; PTCH 72.9% vs. 25% and 0%, P<0.005), but not Gli1 (54.6% vs. 50%, P>0.05). This differentiation revealed that the expression of SHH and PTCH was significantly correlated to histological type and tumor differentiation, whereas Gli1 expression was not correlated with these clinicopathological variables. Additionally, SHH expression exhibited significant differences during TNM stages. (Table IV) . Significant differences were noted in the expression of the three antibodies between the MSI and MSS groups. In general, SHH, Gli1 and PTCH were more frequently expressed in the MSI group compared with the MSS group. Comparison of the expression of Hh signaling pathway is shown in Table V .
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Discussion
MSI in CRC is mainly caused by mutations in the DNA mismatch repair genes hMLH1 and hMSH2, whereas the expression of hMSH6, hPMS1 and hPMS2. The mechanism of tumorigenesis in MSI-H tumors is thought to involve frameshift mutations of microsatellite repeats within coding regions of the affected target genes, and the inactivation of these target genes is believed to directly contribute to tumor development and progression (10) .
A common concept, MSI-H identifies a well-defined subset of CRC that tends to exhibit a diploid state, to be more proximal, poorly differentiated and mucinous, and to have marked lymphocyte infiltration (11) . Thus, MSI genotyping may allow for the identification of discrete molecular CRC subtypes, and MSI appears to be one of the most promising molecular markers with both prognostic and predictive value for chemosensitivity (12) . MSI testing may also result in larger numbers of patients being assigned the appropriate treatment based on their disease profile.
Hh signaling is required for the normal growth and rege neration of organs, such as lung, gastrointestinal tract and prostate, from stem cells. Inappropriate and constitutive activation of the Hedgehog pathway during tissue repair and regeneration may promote tumorigenesis (13) . The SHH signaling pathway may play a central role in the pathogenesis of CRC and the maintenance of Hh signaling pathways for CRC tumorigenesis (14, 15) . In certain tumors, such as basal cell carcinoma and central nervous system tumors, active muta- (13, 16, 17) . The Hh pathway plays a significant role in hepatocellular carcinoma development and invasion (18) . We observed that Hedgehog was much less frequently expressed in MA than in NMA. Previous studies indicated that MSI-H gene alterations were more common in MA than in NMA (19) . Further studies are required to analyze this phenomenon. In our study, SHH and PTCH were more frequently expressed in the MSI group compared with the MSS group. SHH activation was associated with downstream activation of Gli1 and FOXM1 transcription factors known to promote cell proliferation through the induction of the cyclin genes (20, 21) . Gli1 level and activity may thus be modulated by multiple oncogenes and the environment of the cancer cells (22) . We may hypothesize that some of these genes are involved in the Hh signal pathway. However, further analysis of this hypothesis is required. However, whether or not other signaling pathways were involved in impacting the Hh components or mediating the genes in the network of tumorigenesis remains to be determined. The molecular dissection of genes differently expressed in colorectal cancer was provoked by the knowledge that MSI-H colorectal carcinomas are distinguished from MSS carcinomas. Previous studies using oligonucleotide microarray analysis have revealed that there are distinct gene expression profiles in MSI-H and MSS colorectal carcinomas (23) . Although the involvement of the Hh signaling pathway in CRC remains controversial, this is the first time that expression of the Hh signaling pathway has been analyzed in MSS and MSI, demonstrating a molecular signature responsible for CRC. Our study indicates that the expression of the Hh signaling pathway may play a crucial role in MSI for colorectal cancer. However, this mechanism requires further investigation.
